Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Trevena
3157
Trevena
Technology
Biotechnology
Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.
Suggest edits
Founded
2007
Raised
$164M
Follow us
Companies in the same industry
Orthomimetics
Amaryllis Nucleics
Lyndra
Stellar Biotechnologies
Two Pore Guys
C-SATS, Inc.
Histogen Inc.
Sonavex Surgical
Keros Therapeutics, Inc.
Pinteon Therapeutics Inc.
Alexa global traffic share
Twitter followers
Overview
Funding
4
Add info
Latest funding
Show all
$45,000,000
Post-IPO equity - 2014
$60,000,000
Venture capital (Series C) - 2013
Forest Laboratories
Team Size
10+
Employees
I work here
Location
United States
Headquarters
Explore United States
the home of AI info
Trevena Inc. (TRVN)'s Financial Results Comparing With Minerva Neurosciences Inc. (NASDAQ ...
The Motley Fool
Here's Why Trevena Stock Dropped 18% Today
The Motley Fool
Why Trevena Inc.'s Shares Broke Through Today
Health
Stock markets
